SCHEDULE 13G/A: Thrivent Financial Updates Significant Stake in Viemed Healthcare, Holding 6.8% of Common Stock

Sentiment:

Beneficial Ownership Report


Thrivent Financial for Lutherans has filed an Amendment No. 5 to Schedule 13G, disclosing a beneficial ownership of 2,705,000 shares, representing 6.8% of Viemed Healthcare, Inc.'s common stock as of March 31, 2025.

Summary

  • Thrivent Financial for Lutherans, a Wisconsin fraternal benefit society, has filed an Amendment No. 5 to Schedule 13G regarding its beneficial ownership in Viemed Healthcare, Inc.
  • As of March 31, 2025, Thrivent Financial for Lutherans beneficially owns an aggregate of 2,705,000 shares of Viemed Healthcare, Inc. Common Stock.
  • This ownership represents 6.8% of the class, calculated based on 39,521,618 shares outstanding as of February 18, 2025, as stated in Viemed Healthcare's Annual Report on Form 10-K for the year ended December 31, 2024.
  • Thrivent Financial for Lutherans holds sole voting and dispositive power over 14,328 shares, though it disclaims beneficial ownership of these shares, which are held in the Thrivent Financial Defined Benefit Plan Trust.
  • Shared voting and dispositive power is held over 2,690,672 shares.
  • Of the shared shares, 707,051 are held by registered investment companies for which Thrivent Financial for Lutherans serves as investment adviser.
  • The remaining 1,983,621 shared shares are held by registered investment companies for which Thrivent Asset Management, LLC, a wholly-owned subsidiary of Thrivent Financial for Lutherans, serves as investment adviser.
  • The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would significantly alter the sentiment towards the issuer, Viemed Healthcare, Inc. It is a routine regulatory filing.

Positives

  • The disclosure of a significant institutional holding by Thrivent Financial for Lutherans may be viewed as a vote of confidence in Viemed Healthcare, Inc. by a large, established financial entity.

Future Outlook

The document does not contain any forward-looking statements or guidance from Viemed Healthcare, Inc. or Thrivent Financial for Lutherans regarding the issuer's future performance or strategic direction.

Management Comments

  • "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." (Certification by David S. Royal, CFO of Thrivent Financial for Lutherans)

Industry Context

This filing is a routine disclosure of an institutional investor's stake and does not provide specific insights into broader industry trends or Viemed Healthcare's competitive position within the healthcare sector.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional holding, which can influence investor perception and confidence.

Key Dates

DateDescription
2025-02-18Date as of which 39,521,618 shares of Viemed Healthcare, Inc. Common Stock were outstanding, used for percentage calculation.
2025-03-10Date Viemed Healthcare, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2024, was filed with the SEC.
2025-03-31Date of event which requires filing of this statement (beneficial ownership as of this date).
2025-04-29Date the Schedule 13G Amendment No. 5 was signed by David S. Royal, Chief Financial Officer of Thrivent Financial for Lutherans.

Keywords

Viemed Healthcare, Thrivent Financial, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.